Many plan sponsors are rethinking how they validate their pharmacy benefits, as increasing complexity in PBM contract terms, pricing, and performance guarantees continue to evolve.
In this webinar, “Pharmacy Oversight vs. Audit Strategies,” Truveris Chief Strategy Officer Kian Bichoupan will break down the differences between ongoing pharmacy oversight and formal audits, what each is designed to uncover, and where gaps can exist when holding your PBM contract accountable. We’ll explore how continuous pharmacy monitoring can surface discrepancies in real time, why year-end reconciliations are often insufficient, and how targeted audits provide the level of validation needed to confirm contract performance and support fiduciary responsibilities.
Attendees will leave with a clearer understanding of how to evaluate their oversight strategy, when to deploy audits, and how to build a more complete, defensible approach to pharmacy benefits management.
Learning Objectives
- Understand differences between ongoing pharmacy oversight and audits – Recognize how continuous monitoring and retrospective audits serve different roles in evaluating pharmacy benefit performance.
- Assess the limitations of traditional reconciliation approaches – Learn why year-end reviews and PBM-reported performance may not provide a complete picture of contract execution.
- Evaluate when and how to apply audits effectively – Explore common audit types, what they uncover, and how they support deeper validation and stakeholder confidence.
- Determine the role of pharmacy oversight and audits in fiduciary responsibility – Gain perspective on how these approaches support due diligence and more informed decision-making across the pharmacy benefit lifecycle.
About the Speaker:
Kian Bichoupan, PhD, Chief Strategy Officer
Kian brings more than a decade of experience across the pharmacy and healthcare industry, spanning both pharmaceutical manufacturers and pharmacy benefit management. He specializes in procurement and service monitoring for employer plan sponsors and is also a prolific researcher, with more than 50 publications and presentations on healthcare economics, drug pricing, and real-world evidence, primarily focused on infectious diseases.
Truveris is a pharmacy cost containment company dedicated to reducing pharmacy costs and driving transparency for employers and benefit consultants. Our proprietary, data-driven technology and deep industry expertise empower smarter pharmacy benefit decisions through contract optimization and PBM oversight. Independent and unbiased, Truveris delivers measurable savings and accountability across every pharmacy program.
